Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
It is an anti-ulcer peptide (9-12), interacting with NO-system (13), and, unlike other peptides, it is particularly stable in gastric juice (14) and is used consistently without a carrier (9-11, 13-24), being safe in patients with the inflammatory bowel disease (coded PL-10, PLD 116, PL 14736) (21)
Angiogenesis and Vascular Formation BPC-157 demonstrates a unique mechanism by upregulating VEGFR2 expression without affecting VEGF-A levels
Held to the same sourcing and third-party testing standard
The Wolverine Blend is a combination peptide therapy that pairs BPC-157 (Body Protection Compound-157) and TB-500 (a fragment of thymosin beta-4) in a single vial
Patients with this condition typically require injectable B12
Preclinical Safety Evaluation of Body Protective Compound-157, a Potential Drug for Treating Various Wounds
US$ 23.30
US$ 23.77
US$ 28.86
US$ 25.35
US$ 26.01
US$ 20.24
